AEterna Zentaris Inc (NASDAQ:AEZS)

Add to Watch List

Set Alert

1.88 Delayed Data As of Aug 18	+0.01 / +0.53% Today’s Change	0.78 Today\|\|\|52-Week Range 5.59	-47.78% Year-to-Date

1.88

Delayed Data

As of Aug 18

+0.01 / +0.53%

Today’s Change

0.78

Today|||52-Week Range

5.59

-47.78%

Year-to-Date

SECTOR

Health Technology

INDUSTRY

Biotechnology

MARKET CAP

$29.7M

Company Description

Æterna Zentaris, Inc. operates as a specialty biopharmaceutical company that is engaged in developing and commercializing novel treatments in oncology, endocrinology and women's health. The company's pipeline encompasses compounds at all stages of development, from drug discovery through to marketed products. It focuses on the development of Perifosine, Cetrotide, Ozarelix, AEZS-108 and AEZS-130. AEterna Zentaris was founded on September 12, 1990 and is headquartered in Montreal, Canada.

Contact Information

Æterna Zentaris, Inc.

1 Place Marie

Montréal Qu�bec H3B 1R1

P:(514) 847-4747

Investor Relations:
(843) 900-3211

www.aezsinc.com

Employees

Shareholders

Other institutional	4.64%
Mutual fund holders	0.08%
Individual stakeholders	--

Top Executives